世界のメタボロミクス市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metabolomics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4494 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、メタボロミクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分離技術、検出技術、その他）、用途別市場規模（薬物評価、バイオマーカー発見、ニュートリゲノミクス、臨床毒物学、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・メタボロミクスの市場動向 ・企業の競争状況、市場シェア ・メタボロミクスの種類別市場規模と予測2016-2027（分離技術、検出技術、その他） ・メタボロミクスの用途別市場規模と予測2016-2027（薬物評価、バイオマーカー発見、ニュートリゲノミクス、臨床毒物学、その他） ・メタボロミクスの北米市場規模2016-2027（アメリカ、カナダ） ・メタボロミクスの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・メタボロミクスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メタボロミクスの中南米市場規模2016-2027（メキシコ、ブラジル） ・メタボロミクスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific, Inc.、Agilent Technologies, Inc.、Biocrates Life Sciences AG、Shimadzu Corporation、Waters Corporation、Human Metabolome Technologies, Inc.、LECO Corporation、Metabolon, Inc.、Bio-Rad Laboratories, Inc.、Bruker Corporation） ・結論

Market Analysis and Insights: Global Metabolomics Market
The global Metabolomics market size is projected to reach US$ 3061 million by 2027, from US$ 1422.7 million in 2020, at a CAGR of 11.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolomics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolomics market.

Global Metabolomics Scope and Market Size
Metabolomics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabolomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Separation Techniques
Detection Techniques
Others

Segment by Application
Drug Assessment
Biomarker Discovery
Nutrigenomics
Clinical toxicology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Biocrates Life Sciences AG
Shimadzu Corporation
Waters Corporation
Human Metabolome Technologies, Inc.
LECO Corporation
Metabolon, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Separation Techniques
1.2.3 Detection Techniques
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metabolomics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Assessment
1.3.3 Biomarker Discovery
1.3.4 Nutrigenomics
1.3.5 Clinical toxicology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metabolomics Market Perspective (2016-2027)
2.2 Metabolomics Growth Trends by Regions
2.2.1 Metabolomics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metabolomics Historic Market Share by Regions (2016-2021)
2.2.3 Metabolomics Forecasted Market Size by Regions (2022-2027)
2.3 Metabolomics Industry Dynamic
2.3.1 Metabolomics Market Trends
2.3.2 Metabolomics Market Drivers
2.3.3 Metabolomics Market Challenges
2.3.4 Metabolomics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Players by Revenue
3.1.1 Global Top Metabolomics Players by Revenue (2016-2021)
3.1.2 Global Metabolomics Revenue Market Share by Players (2016-2021)
3.2 Global Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Revenue
3.4 Global Metabolomics Market Concentration Ratio
3.4.1 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Revenue in 2020
3.5 Metabolomics Key Players Head office and Area Served
3.6 Key Players Metabolomics Product Solution and Service
3.7 Date of Enter into Metabolomics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolomics Breakdown Data by Type
4.1 Global Metabolomics Historic Market Size by Type (2016-2021)
4.2 Global Metabolomics Forecasted Market Size by Type (2022-2027)

5 Metabolomics Breakdown Data by Application
5.1 Global Metabolomics Historic Market Size by Application (2016-2021)
5.2 Global Metabolomics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metabolomics Market Size (2016-2027)
6.2 North America Metabolomics Market Size by Type
6.2.1 North America Metabolomics Market Size by Type (2016-2021)
6.2.2 North America Metabolomics Market Size by Type (2022-2027)
6.2.3 North America Metabolomics Market Size by Type (2016-2027)
6.3 North America Metabolomics Market Size by Application
6.3.1 North America Metabolomics Market Size by Application (2016-2021)
6.3.2 North America Metabolomics Market Size by Application (2022-2027)
6.3.3 North America Metabolomics Market Size by Application (2016-2027)
6.4 North America Metabolomics Market Size by Country
6.4.1 North America Metabolomics Market Size by Country (2016-2021)
6.4.2 North America Metabolomics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metabolomics Market Size (2016-2027)
7.2 Europe Metabolomics Market Size by Type
7.2.1 Europe Metabolomics Market Size by Type (2016-2021)
7.2.2 Europe Metabolomics Market Size by Type (2022-2027)
7.2.3 Europe Metabolomics Market Size by Type (2016-2027)
7.3 Europe Metabolomics Market Size by Application
7.3.1 Europe Metabolomics Market Size by Application (2016-2021)
7.3.2 Europe Metabolomics Market Size by Application (2022-2027)
7.3.3 Europe Metabolomics Market Size by Application (2016-2027)
7.4 Europe Metabolomics Market Size by Country
7.4.1 Europe Metabolomics Market Size by Country (2016-2021)
7.4.2 Europe Metabolomics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Market Size (2016-2027)
8.2 Asia-Pacific Metabolomics Market Size by Type
8.2.1 Asia-Pacific Metabolomics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metabolomics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metabolomics Market Size by Type (2016-2027)
8.3 Asia-Pacific Metabolomics Market Size by Application
8.3.1 Asia-Pacific Metabolomics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metabolomics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metabolomics Market Size by Application (2016-2027)
8.4 Asia-Pacific Metabolomics Market Size by Region
8.4.1 Asia-Pacific Metabolomics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metabolomics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metabolomics Market Size (2016-2027)
9.2 Latin America Metabolomics Market Size by Type
9.2.1 Latin America Metabolomics Market Size by Type (2016-2021)
9.2.2 Latin America Metabolomics Market Size by Type (2022-2027)
9.2.3 Latin America Metabolomics Market Size by Type (2016-2027)
9.3 Latin America Metabolomics Market Size by Application
9.3.1 Latin America Metabolomics Market Size by Application (2016-2021)
9.3.2 Latin America Metabolomics Market Size by Application (2022-2027)
9.3.3 Latin America Metabolomics Market Size by Application (2016-2027)
9.4 Latin America Metabolomics Market Size by Country
9.4.1 Latin America Metabolomics Market Size by Country (2016-2021)
9.4.2 Latin America Metabolomics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Market Size (2016-2027)
10.2 Middle East & Africa Metabolomics Market Size by Type
10.2.1 Middle East & Africa Metabolomics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metabolomics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metabolomics Market Size by Type (2016-2027)
10.3 Middle East & Africa Metabolomics Market Size by Application
10.3.1 Middle East & Africa Metabolomics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metabolomics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metabolomics Market Size by Application (2016-2027)
10.4 Middle East & Africa Metabolomics Market Size by Country
10.4.1 Middle East & Africa Metabolomics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metabolomics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Metabolomics Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2016-2021)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Metabolomics Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Metabolomics Business (2016-2021)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 Biocrates Life Sciences AG
11.3.1 Biocrates Life Sciences AG Company Details
11.3.2 Biocrates Life Sciences AG Business Overview
11.3.3 Biocrates Life Sciences AG Metabolomics Introduction
11.3.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2016-2021)
11.3.5 Biocrates Life Sciences AG Recent Development
11.4 Shimadzu Corporation
11.4.1 Shimadzu Corporation Company Details
11.4.2 Shimadzu Corporation Business Overview
11.4.3 Shimadzu Corporation Metabolomics Introduction
11.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2016-2021)
11.4.5 Shimadzu Corporation Recent Development
11.5 Waters Corporation
11.5.1 Waters Corporation Company Details
11.5.2 Waters Corporation Business Overview
11.5.3 Waters Corporation Metabolomics Introduction
11.5.4 Waters Corporation Revenue in Metabolomics Business (2016-2021)
11.5.5 Waters Corporation Recent Development
11.6 Human Metabolome Technologies, Inc.
11.6.1 Human Metabolome Technologies, Inc. Company Details
11.6.2 Human Metabolome Technologies, Inc. Business Overview
11.6.3 Human Metabolome Technologies, Inc. Metabolomics Introduction
11.6.4 Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2016-2021)
11.6.5 Human Metabolome Technologies, Inc. Recent Development
11.7 LECO Corporation
11.7.1 LECO Corporation Company Details
11.7.2 LECO Corporation Business Overview
11.7.3 LECO Corporation Metabolomics Introduction
11.7.4 LECO Corporation Revenue in Metabolomics Business (2016-2021)
11.7.5 LECO Corporation Recent Development
11.8 Metabolon, Inc.
11.8.1 Metabolon, Inc. Company Details
11.8.2 Metabolon, Inc. Business Overview
11.8.3 Metabolon, Inc. Metabolomics Introduction
11.8.4 Metabolon, Inc. Revenue in Metabolomics Business (2016-2021)
11.8.5 Metabolon, Inc. Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. Metabolomics Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2016-2021)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Bruker Corporation
11.10.1 Bruker Corporation Company Details
11.10.2 Bruker Corporation Business Overview
11.10.3 Bruker Corporation Metabolomics Introduction
11.10.4 Bruker Corporation Revenue in Metabolomics Business (2016-2021)
11.10.5 Bruker Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metabolomics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Separation Techniques
Table 3. Key Players of Detection Techniques
Table 4. Key Players of Others
Table 5. Global Metabolomics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metabolomics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metabolomics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Metabolomics Market Share by Regions (2016-2021)
Table 9. Global Metabolomics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Metabolomics Market Share by Regions (2022-2027)
Table 11. Metabolomics Market Trends
Table 12. Metabolomics Market Drivers
Table 13. Metabolomics Market Challenges
Table 14. Metabolomics Market Restraints
Table 15. Global Metabolomics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Metabolomics Market Share by Players (2016-2021)
Table 17. Global Top Metabolomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolomics as of 2020)
Table 18. Ranking of Global Top Metabolomics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Metabolomics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metabolomics Product Solution and Service
Table 22. Date of Enter into Metabolomics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metabolomics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Metabolomics Revenue Market Share by Type (2016-2021)
Table 26. Global Metabolomics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Metabolomics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Metabolomics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Metabolomics Revenue Market Share by Application (2016-2021)
Table 30. Global Metabolomics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Metabolomics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Metabolomics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Metabolomics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Metabolomics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Metabolomics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Metabolomics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Metabolomics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Metabolomics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Metabolomics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Metabolomics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Metabolomics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Metabolomics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Metabolomics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Metabolomics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Metabolomics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metabolomics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metabolomics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metabolomics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Metabolomics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Metabolomics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Metabolomics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Metabolomics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Metabolomics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Metabolomics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Metabolomics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Metabolomics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Metabolomics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metabolomics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metabolomics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metabolomics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Metabolomics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific, Inc. Company Details
Table 63. Thermo Fisher Scientific, Inc. Business Overview
Table 64. Thermo Fisher Scientific, Inc. Metabolomics Product
Table 65. Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific, Inc. Recent Development
Table 67. Agilent Technologies, Inc. Company Details
Table 68. Agilent Technologies, Inc. Business Overview
Table 69. Agilent Technologies, Inc. Metabolomics Product
Table 70. Agilent Technologies, Inc. Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 71. Agilent Technologies, Inc. Recent Development
Table 72. Biocrates Life Sciences AG Company Details
Table 73. Biocrates Life Sciences AG Business Overview
Table 74. Biocrates Life Sciences AG Metabolomics Product
Table 75. Biocrates Life Sciences AG Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 76. Biocrates Life Sciences AG Recent Development
Table 77. Shimadzu Corporation Company Details
Table 78. Shimadzu Corporation Business Overview
Table 79. Shimadzu Corporation Metabolomics Product
Table 80. Shimadzu Corporation Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 81. Shimadzu Corporation Recent Development
Table 82. Waters Corporation Company Details
Table 83. Waters Corporation Business Overview
Table 84. Waters Corporation Metabolomics Product
Table 85. Waters Corporation Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 86. Waters Corporation Recent Development
Table 87. Human Metabolome Technologies, Inc. Company Details
Table 88. Human Metabolome Technologies, Inc. Business Overview
Table 89. Human Metabolome Technologies, Inc. Metabolomics Product
Table 90. Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 91. Human Metabolome Technologies, Inc. Recent Development
Table 92. LECO Corporation Company Details
Table 93. LECO Corporation Business Overview
Table 94. LECO Corporation Metabolomics Product
Table 95. LECO Corporation Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 96. LECO Corporation Recent Development
Table 97. Metabolon, Inc. Company Details
Table 98. Metabolon, Inc. Business Overview
Table 99. Metabolon, Inc. Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 100. Metabolon, Inc. Recent Development
Table 101. Bio-Rad Laboratories, Inc. Company Details
Table 102. Bio-Rad Laboratories, Inc. Business Overview
Table 103. Bio-Rad Laboratories, Inc. Metabolomics Product
Table 104. Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 105. Bio-Rad Laboratories, Inc. Recent Development
Table 106. Bruker Corporation Company Details
Table 107. Bruker Corporation Business Overview
Table 108. Bruker Corporation Metabolomics Product
Table 109. Bruker Corporation Revenue in Metabolomics Business (2016-2021) & (US$ Million)
Table 110. Bruker Corporation Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolomics Market Share by Type: 2020 VS 2027
Figure 2. Separation Techniques Features
Figure 3. Detection Techniques Features
Figure 4. Others Features
Figure 5. Global Metabolomics Market Share by Application: 2020 VS 2027
Figure 6. Drug Assessment Case Studies
Figure 7. Biomarker Discovery Case Studies
Figure 8. Nutrigenomics Case Studies
Figure 9. Clinical toxicology Case Studies
Figure 10. Others Case Studies
Figure 11. Metabolomics Report Years Considered
Figure 12. Global Metabolomics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Metabolomics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Metabolomics Market Share by Regions: 2020 VS 2027
Figure 15. Global Metabolomics Market Share by Regions (2022-2027)
Figure 16. Global Metabolomics Market Share by Players in 2020
Figure 17. Global Top Metabolomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolomics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Metabolomics Revenue in 2020
Figure 19. Global Metabolomics Revenue Market Share by Type (2016-2021)
Figure 20. Global Metabolomics Revenue Market Share by Type (2022-2027)
Figure 21. North America Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Metabolomics Market Share by Type (2016-2027)
Figure 23. North America Metabolomics Market Share by Application (2016-2027)
Figure 24. North America Metabolomics Market Share by Country (2016-2027)
Figure 25. United States Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metabolomics Market Share by Type (2016-2027)
Figure 29. Europe Metabolomics Market Share by Application (2016-2027)
Figure 30. Europe Metabolomics Market Share by Country (2016-2027)
Figure 31. Germany Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metabolomics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Metabolomics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Metabolomics Market Share by Region (2016-2027)
Figure 41. China Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metabolomics Market Share by Type (2016-2027)
Figure 49. Latin America Metabolomics Market Share by Application (2016-2027)
Figure 50. Latin America Metabolomics Market Share by Country (2016-2027)
Figure 51. Mexico Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metabolomics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Metabolomics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Metabolomics Market Share by Country (2016-2027)
Figure 57. Turkey Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Metabolomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 61. Agilent Technologies, Inc. Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 62. Biocrates Life Sciences AG Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 63. Shimadzu Corporation Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 64. Waters Corporation Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 65. Human Metabolome Technologies, Inc. Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 66. LECO Corporation Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 67. Metabolon, Inc. Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 68. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 69. Bruker Corporation Revenue Growth Rate in Metabolomics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---